Enterohemorrhagic and other Shigatoxin-producing Escherichia coli - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 174

Whale, A.D., Hernandes, R.T., Ooka, T., et al., 2007. TccP2-mediated subversion of actin
dynamics by EPEC 2 -a distinct evolutionary lineage of enteropathogenic Escherichia coli .
Microbiology 153 (Pt 6), 1743-1755 .
Whittam, T.S., 1998. Evolution of Escherichia coli O157:H7 and other Shiga toxin-producing
E. coli strains. Escherichia coli O157:H7 and Other Shiga Toxin-producing E. coli Strains.
In: Kaper, J.B., O'Brien, A.D. (Eds.), American Society for Microbiology, Washington, D.C,
pp. 195-212 .
Wick, L.M., Qi, W., Lacher, D.W., et al., 2005. Evolution of genomic content in the stepwise
emergence of Escherichia coli O157:H7. J. Bacteriol. 187 (5), 1783-1791 .
Wolfson, J.J., Jandhyala, D.M., Gorczyca, L.A., et al., 2009. Prevalence of the operon encoding
subtilase cytotoxin in non-O157 Shiga toxin-producing Escherichia coli isolated from humans
in the United States. J. Clin. Microbiol. 47 (9), 3058-3059 .
Wolfson, J.J., May, K.L., Thorpe, C.M., et al., 2008. Subtilase cytotoxin activates PERK,
IRE1 and ATF6 endoplasmic reticulum stress-signalling pathways. Cell Microbiol. 10 (9),
1775-1786 .
Wong, A.R., Clements, A., Raymond, B., et al., 2012a. The interplay between the Escherichia coli
Rho guanine nucleotide exchange factor effectors and the mammalian RhoGEF inhibitor EspH.
MBio 3 (1) .
Wong, A.R., Pearson, J.S., Bright, M.D., et al., 2011. Enteropathogenic and enterohaemorrhagic
Escherichia coli : even more subversive elements. Mol. Microbiol. 80 (6), 1420-1438 .
Wong, A.R., Raymond, B., Collins, J.W., et al., 2012b. The enteropathogenic E. coli effector EspH
promotes actin pedestal formation and elongation via WASP-interacting protein (WIP). Cell
Microbiol. 14 (7), 1051-1070 .
Wong, C.S., Jelacic, S., Habeeb, R.L., et al., 2000. The risk of the hemolytic-uremic syndrome
after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J. Med. 342 (26),
1930-1936 .
Wu, B., Skarina, T., Yee, A., et al., 2010. NleG Type 3 effectors from enterohaemorrhagic
Escherichia coli are U-Box E3 ubiquitin ligases. PLoS Pathog. 6 (6), e1000960 .
Wu, C.J., Hsueh, P.R., Ko, W.C., 2011. A new health threat in Europe: Shiga toxin-producing
Escherichia coli O104:H4 infections. J. Microbiol. Immunol. Infect. 44 (5), 390-393 .
Xicohtencatl-Cortes, J., Monteiro-Neto, V., Ledesma, M.A., et al., 2007. Intestinal adherence
associated with type IV pili of enterohemorrhagic Escherichia coli O157:H7. J. Clin. Invest.
117 (11), 3519-3529 .
Xicohtencatl-Cortes, J., Monteiro-Neto, V., Saldana, Z., et al., 2009a. The type 4 pili of enterohe-
morrhagic Escherichia coli O157:H7 are multipurpose structures with pathogenic attributes.
J. Bacteriol. 191 (1), 411-421 .
Xicohtencatl-Cortes, J., Sanchez Chacon, E., Saldana, Z., et al., 2009b. Interaction of Escherichia
coli O157:H7 with leafy green produce. J. Food Prot. 72 (7), 1531-1537 .
Yamada, S., Matsushita, S., Kai, A., et al., 1993. Detection of verocytotoxin from stool and serologi-
cal testing of patients with diarrhea caused by Escherichia coli O157: H7. Microbiol. Immunol.
37 (2), 111-118 .
Yen, H., Ooka, T., Iguchi, A., et al., 2010. NleC, a type III secretion protease, compromises NF-
kappaB activation by targeting p65/RelA. PLoS Pathog. 6 (12), e1001231 .
Yi, Y., Ma, Y., Gao, F., et al., 2010. Crystal structure of EHEC intimin: insights into the complemen-
tarity between EPEC and EHEC. PLoS One 5 (12), e15285 .
Yokoyama, E., Etoh, Y., Ichihara, S., et al., 2011. Emergence of enterohemorrhagic Escherichia coli
serovar O157 strains in clade 8 with highly similar pulsed-ield gel electrophoresis patterns.
J. Food Prot. 74 (8), 1324-1327 .